COMMUNIQUÉS West-GlobeNewswire

Retrieve Medical Announces Significant Results from Physician Burnout Study

02/05/2024 - 18:58

BEDMINSTER, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) unveils significant breakthroughs from its recent examination into Physician Burnout. The study has illuminated a [...]

Ibogaine By David Dardashti Pioneers Work on Quantum Electrodynamics Prototype

02/05/2024 - 18:57

A Groundbreaking Innovation Set To Make A Difference MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- Ibogaine by David Dardashti looks to revolutionize the field of ibogaine addiction treatment through its recent exploration of [...]

Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access Commission

02/05/2024 - 18:54

MCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, [...]

Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2023

02/05/2024 - 18:00

Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2023 Nantes, le 2 mai 2024 – OSE Immunotherapeutics SA ( ISIN: FR0012127173; Mnémo: OSE) annonce la mise à disposition de son [...]

Number of voting rights as of April 30, 2024

02/05/2024 - 17:45

Nicox SA Société anonyme with a registered capital of € 50,299,694 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois – 06410 Biot R.C.S. ANTIBES 403.942.642 On May 2 nd , 2024, MONTHLY [...]

Nombre de droits de vote au 30 avril 2024

02/05/2024 - 17:45

Nicox SA Société anonyme au capital de 50 299 694 euros Siège social : Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois, 06410 Biot R.C.S. ANTIBES 403.942.642 Le 02 mai 2024, PUBLICATION MENSUELLE DU NOMBRE [...]

Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe

02/05/2024 - 17:30

Extended contract now covers a total of 11 European countries Crossject will receive milestone payments of up to €1 million in total, upon marketing authorizations Crossject will sell ZEPIZURE® to the partner with a [...]

Crossject signe une extension géographique de l'accord de commercialisation de ZEPIZURE® en Europe

02/05/2024 - 17:30

Le contrat couvre désormais un total de 11 pays européens Crossject recevra des paiements d’étape pour un montant total pouvant aller jusqu’à un million d’euros, dès l’obtention des autorisations de mise sur le marché [...]

CirrusMD's Physician-first Virtual Care Now Accessible Via Partnership with Blackwell Captive Solutions, Changing Healthcare Delivery in the U.S.

02/05/2024 - 17:13

ful.Health Partners with Blackwell Captive Solutions to Deliver Innovative Cost-Containment Solutions, Featuring CirrusMD's Physician-Led Care, Ensuring Payers Benefit from Enhanced Savings and Superior Healthcare. [...]

Genmab Announces Financial Results for the First Quarter of 2024

02/05/2024 - 17:01

May 2, 2024 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2024 Highlights The U.S. Food and Drug Administration (U.S. FDA) granted Priority Review for the supplemental Biologics License [...]

American Nurses Association Presents Nurses Week 2024 – Nurses Make the Difference

02/05/2024 - 15:33

This year's theme, "Nurses Make the Difference," honors the incredible nurses who embody the spirit of compassion and care in every health care setting. SILVER SPRING, MD, May 02, 2024 (GLOBE NEWSWIRE) -- The American [...]

Team Member Feedback Earns HealthEquity Workplace Culture Recognition

02/05/2024 - 15:20

For the fourth consecutive year, team members' feedback has propelled HealthEquity to be recognized for cultural excellence DRAPER, Utah, May 02, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation’s [...]

Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

02/05/2024 - 15:15

ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI ) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic [...]

Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02/05/2024 - 15:15

New role enhances company’s strong leadership team and solidifies commitment to ongoing clinical innovation DOYLESTOWN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “ [...]

KFSH&RC Ranked Top Valuable Healthcare Brand in Saudi Arabia and Middle East

02/05/2024 - 15:09

RIYADH, Saudi Arabia, May 02, 2024 (GLOBE NEWSWIRE) -- KFSH&RC tops the healthcare sector in the Kingdom of Saudi Arabia and the Middle East, recognizing it as the most valuable healthcare brand in these regions for [...]

Kriya Announces Three Presentations at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

02/05/2024 - 15:05

– Kriya is developing KRIYA-825 as a potential one-time gene therapy expressing a fusion protein inhibiting the activity of complement C3 and C5 for the treatment of Geographic Atrophy – PALO ALTO, Calif. and RESEARCH [...]

Outlook Therapeutics® to Present at the Retina World Congress 2024

02/05/2024 - 15:05

ISELIN, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment [...]

ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics

02/05/2024 - 15:00

New research collaboration will explore the differentiation of eblasakimab's mechanism of action versus biologic therapies for atopic dermatitis (AD), dupilumab and lebrikizumab . The findings will deepen understanding [...]

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

02/05/2024 - 15:00

Continuous blood glucose monitor’s preclinical data and sensor longevity modeling to be presented at major diabetes conference Rutherford, NJ, May 02, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“ [...]